FDA & multiplicity [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2012-12-01 03:00 (4959 d 21:13 ago) – Posting: # 9651
Views: 25,088

Hi John,

❝ Zipped some absinthe while refreshing my PK memory this afternoon.


Nice stuff. Prefer it in the late evening. ;-)

❝ My old boss filed a 4-way nifedpine study and if I recall correctly the statistic was straight forward and FDA didn't come back with questions on multiplicity. I recalled we filed the product back in 1997 (Good old days when I was hired as an university summer intern).


Yeah, the mid-1990s – the golden age of MR nifedipine. Analysed ~20,000 samples if I recall it right.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
345 visitors (0 registered, 345 guests [including 44 identified bots]).
Forum time: 01:13 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5